相关实验视频
Updated: Jul 15, 2025

07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
13.8K
无细胞DNA作为慢性病的可信生物标志物
Tetiana A Berezina1, Alexander E Berezin2
1VitaCenter, Department of Internal Medicine and Nephrology, Zaporozhye, 69000, Ukraine.
Epigenomics
|October 4, 2023
概括
循环无细胞DNA (cf-DNA) 显示出作为病进展和死亡风险的非侵入性生物标志物的潜力. 监测cf-DNA动态可能有助于预测慢性病,并指导末期病患者的治疗.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 循环的无细胞DNA (cf-DNA) 来自白细胞亡和中性粒细胞外细胞陷,表明炎症过程.
- 之前的研究表明,cf-DNA水平可以非侵入性地表明功能下降和异种移植排斥.
- cf-DNA在预测慢性病 (CKD) 和末期病 (ESKD) 死亡率方面的作用需要进一步调查.
研究的目的:
- 研究cf-DNA模式作为一种预测性生物标志物,用于2型糖尿病,心力衰竭和心血管疾病患者的CKD风险.
- 评估cf-DNA作为ESKD患者全因死亡率的预测指标,特别是分析血液透析前和后的水平.
主要方法:
- 循环无细胞DNA (cf-DNA) 水平和动态变化的分析.
- cf-DNA模式与患慢性病 (CKD) 风险的相关性.
- 血清cf-DNA水平在血液透析前和之后的评估,作为末期脏疾病 (ESKD) 死亡率的预测指标.
主要成果:
- 假设cf-DNA模式和动态可以作为CKD风险的预测生物标志物.
- 确定了血液透析前和后的cf-DNA水平,作为ESKD患者全因死亡率的独立预测指标.
结论:
- 循环无细胞DNA (cf-DNA) 作为预测慢性病 (CKD) 发展和进展的非侵入性生物标志物具有前途.
- 监测cf-DNA动态,特别是与血液透析有关的动态,可能为末期病 (ESKD) 患者的死亡风险提供有价值的见解.
相关概念视频
Chronic Kidney Disease I: Introduction
19
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
19
Chronic Kidney Disease III: Interprofessional Care
26
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
26
Chronic Kidney Disease II: Clinical Manifestations
13
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
13
Acute Kidney Injury IV: Diagnostic Studies and Prevention
21
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Factors Affecting Renal Clearance: Renal Impairment
105
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
105
Serum Studies: Renal Function Tests
9
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9

